Tag Archives: Envisagenics

Envisagenics, Inc., a New York-based biotechnology company leveraging artificial intelligence (AI) and RNA-splicing analytics for discovery and development of disease specific therapeutics, announced today...

Envisagenics, Inc., a New York based biotechnology company, announced today that it was awarded a Small Business Innovation Research (SBIR) Phase II grant from the National Institutes of Health (NIH). This grant will provide $1.5 million over two years for Envisagenics’ ...

Envisagenics is the developer of SpliceCore, software that analyzes RNA sequencing (RNA-seq) data to accelerate RNA therapeutics discovery using innovative machine learning to identify new...

Envisagenics, Inc., a biotechnology company that applies Artificial Intelligence to the genetic sequence of patients to discover new therapies, announced today that is has raised $2.35M in its seed round. The investors include Third Kind Venture Capital (3KVC), Cosine, LLC ...

About Envisagenics Envisagenics is a bioinformatics startup developing cloud-based solutions to leverage biomedical big data and accelerate R&D therapeutics through machine learning. Envisagenics is a spin-off from Cold Spring Harbor Laboratory, a biomedical research institute ranked #1 worldwide for scientific impact ...

Breakout Labs, the Thiel Foundation’s seed-stage fund for deep technology companies, announced its latest four investments, each propelling radical science and technology to improve human health. The new awards bring the total number of companies backed by Breakout Labs to ...